UFC1 and liver disorder: In summary, our results suggest that UFC1 (4′,′5-(Methylenedioxy)-2-nitrocinnamic acid) may interact directly with Z-hAAT and render the protein susceptible to degradation mechanisms within cells in a manner beneficial for AATD associated liver disease.